Lista de obras - Mariano Ponz-Sarvise - Dominio Público Uruguay

Acquired nasopharyngeal stenosis: surgical treatment for this unusual complication after chemoradiation for nasopharyngeal carcinoma

artículo científico publicado en 2007

Adjuvant therapy for colon cancer: genes, genes... and the patient in the center

artículo científico publicado en 2018

An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer.

artículo científico publicado en 2017

Association of RRM1 –37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapy

artículo científico publicado en 2011

BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

artículo científico publicado en 2020

Brachytherapy attains abscopal effects when combined with immunostimulatory monoclonal antibodies

artículo científico publicado en 2017

CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity

artículo científico publicado en 2020

Clinical presentation, diagnosis and staging of cholangiocarcinoma

artículo científico publicado en 2019

Differential tumor expression of inhibitor of differentiation-1 in prostate cancer patients with extreme clinical phenotypes and prognostic implications

artículo científico publicado en 2013

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer.

artículo científico publicado en 2017

Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients

artículo científico publicado en 2010

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?

artículo científico publicado en 2007

FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted

artículo científico publicado en 2021

Genetic Mouse Models as In Vivo Tools for Cholangiocarcinoma Research

scientific article published on 26 November 2019

Id-1 expression and prognosis in cancer: do antibodies matter?

scientific article published on 01 January 2010

Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer

scientific article published on 06 September 2019

Immunotherapy of Cancer Visualized by Live Microscopy: Seeing Is Believing

scientific article published on 21 June 2016

Improving disease control in advanced colorectal cancer: Panitumumab and cetuximab

artículo científico publicado en 2009

In Which Journals Do Active Researchers of Palliative Care Publish Their Articles?

artículo científico publicado en 2011

Inhibitor of Differentiation-1 Sustains Mutant KRAS-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network

artículo científico publicado en 2018

Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance

artículo científico publicado en 2011

Interleukin-8 in cancer pathogenesis, treatment and follow-up

artículo científico publicado en 2017

Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors

artículo científico publicado en 2020

Is There Any Reason to Delay Introduction of Tumor Necrosis Factor in the Management of In-Transit Metastasis of Unresectable Melanoma?

artículo científico publicado en 2007

Mouse Models of Pancreatic Ductal Adenocarcinoma

artículo científico

NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer

artículo científico publicado en 2016

Organoid models of human and mouse ductal pancreatic cancer

artículo científico publicado en 2014

Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis

artículo científico publicado en 2010

Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825).

artículo científico publicado en 2007

Preliminary results of the combination of bevacizumab and weekly Paclitaxel in advanced melanoma

artículo científico publicado en 2008

Proteasome inhibition enhances the killing effect of BikDD gene therapy

artículo científico publicado en 2015

Response of resistant melanoma to a combination of weekly paclitaxel and bevacizumab

artículo científico publicado en 2007

Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer

artículo científico publicado en 2016

S6K1 promotes invasiveness of breast cancer cells in a model of metastasis of triple-negative breast cancer

artículo científico publicado en 2014

TGFBI expression is associated with a better response to chemotherapy in NSCLC.

artículo científico publicado en 2010

TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies

artículo científico publicado en 2019

The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas

artículo científico publicado en 2020

The RAS and YAP1 dance, who is leading?

artículo científico publicado en 2014

Use of Machine-Learning Algorithms in Intensified Preoperative Therapy of Pancreatic Cancer to Predict Individual Risk of Relapse

artículo científico publicado en 2019

Vaccination for Pancreatic Ductal Adenocarcinoma: A Hard Nut to Crack

scientific article published on 17 July 2019

Lista de obras de Mariano Ponz-Sarvise

Acquired nasopharyngeal stenosis: surgical treatment for this unusual complication after chemoradiation for nasopharyngeal carcinoma

Adjuvant therapy for colon cancer: genes, genes... and the patient in the center

An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer.

Association of RRM1 –37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapy

BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

Brachytherapy attains abscopal effects when combined with immunostimulatory monoclonal antibodies

CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity

Clinical presentation, diagnosis and staging of cholangiocarcinoma

Differential tumor expression of inhibitor of differentiation-1 in prostate cancer patients with extreme clinical phenotypes and prognostic implications

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer.

Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?

FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted

Genetic Mouse Models as In Vivo Tools for Cholangiocarcinoma Research

Id-1 expression and prognosis in cancer: do antibodies matter?

Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer

Immunotherapy of Cancer Visualized by Live Microscopy: Seeing Is Believing

Improving disease control in advanced colorectal cancer: Panitumumab and cetuximab

In Which Journals Do Active Researchers of Palliative Care Publish Their Articles?

Inhibitor of Differentiation-1 Sustains Mutant KRAS-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network

Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance

Interleukin-8 in cancer pathogenesis, treatment and follow-up

Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors

Is There Any Reason to Delay Introduction of Tumor Necrosis Factor in the Management of In-Transit Metastasis of Unresectable Melanoma?

Mouse Models of Pancreatic Ductal Adenocarcinoma

NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer

Organoid models of human and mouse ductal pancreatic cancer

Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis

Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825).

Preliminary results of the combination of bevacizumab and weekly Paclitaxel in advanced melanoma

Proteasome inhibition enhances the killing effect of BikDD gene therapy

Response of resistant melanoma to a combination of weekly paclitaxel and bevacizumab

Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer

S6K1 promotes invasiveness of breast cancer cells in a model of metastasis of triple-negative breast cancer

TGFBI expression is associated with a better response to chemotherapy in NSCLC.

TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies

The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas

The RAS and YAP1 dance, who is leading?

Use of Machine-Learning Algorithms in Intensified Preoperative Therapy of Pancreatic Cancer to Predict Individual Risk of Relapse

Vaccination for Pancreatic Ductal Adenocarcinoma: A Hard Nut to Crack